Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies
The summary for the Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies: The NINDS invites applications to validate animal models of pharmacoresistant epilepsy or intervention in the epileptogenic processes leading to chronic disease. The goal of this grant program is to validate proposed models of pharmacoresistant epilepsy and/or antiepileptogenic models for use in drug discovery. It will establish baseline data and introduce new methods for evaluating the therapeutic potential of novel compounds for the treatment of epilepsy.
Federal Grant Title: | Model Validation for Antiepileptogenic and Resistant Epilepsy Therapies |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-NS-04-002 |
Type of Funding: | Grant |
CFDA Numbers: | 93.853 |
CFDA Descriptions: | Extramural Research Programs in the Neurosciences and Neurological Disorders |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Nov 21, 2003 |
Posted Date: | Aug 22, 2003 |
Creation Date: | Dec 21, 2003 |
Archive Date: | Dec 21, 2003 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...
- • Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contribution...
- • Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging fin...
- • NINDS Program Project Grant (P01 Clinical Trial Optional)
- • NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
- • NINDS Institutional Center Core Grants to Support Neuroscience Research
- • Career Development Award to Promote Diversity in Neuroscience Research
- More Grants from the National Institutes of Health
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...